vaccine is a very important issue. Currently, we are looking for a partnership with India. We believe that they are capable of producing the Gamaleya vaccine and it is very important to say that those partnerships to produce the vaccine will enable us to cover the demand that we have," he said.Dmitriev said Russia is looking forward to international cooperation."We are going to do clinical trials not just in Russia but also in the UAE, Saudi Arabia, probably in Brazil and India.
We are planning to produce the vaccine in more than five countries and there is a very high demand from Asia, Latin America, Italy and other parts of the world regarding the delivery of the vaccine," he said.Alexander Gintsburg, the director of the Gamaleya Research.